Event Date

August 12-14, 2021

Event Location

Shanghai, China

Send us an email

sarah@istci.org

Register Now!

Save $200 for Earlybird

 
Six Symposiums
   

Symposium on Recent Advancements on Drug Discovery Science and Technology

 

Symposium on Novel Drug Delivery Systems and Technology

 

Symposium on New Discoveries and Achievements of Cancer Research

 

Symposium on Latest Advances in Cardiovascular Research and Therapeutics Development

 

Symposium on Innovation on CNS Research and Therapeutics Development

 

Symposium on Updates on Diabetes Research and Therapy


Sub-Meeting
 

Latest News

•  Online Registration is Open
October 1st, 2019

•  Call for speakers!
September 1st, 2019

•  Welcome to the website of  WCDI-2021

August 15th, 2019

 
Important Dates

•  Abstract Submission Start Day
September 1st, 2019

•  Earlybird Registration Start Day
October 1st, 2019

•  Earlybird Registration Deadline
December 31st, 2019

•  Abstract Submission Deadline
June 30th, 2021

•  Acceptance Notification Deadline
July 20 th, 2021

 
 


 
Postpone Notice

World Congress on Drug Innovation (WCDI) is designed for inspiring international and interdisciplinary exchange at the forefront of drug research and to accelerate the cooperation for new drug research and development, and novel DDS technologies in the global market. The conference feature talks from Recent Advancements on Drug Discovery Science and Technology to Novel Drug Delivery Systems and Technology. During this special period of global pandemic, WCDI-2020 has to be postponed to next year. Instead, we provide online talk series for scientists, researchers, entrepreneurs, and decision makers from all over the world to debate on the latest scientific advances in the field of drug discovery & delivery that help to shape current and future challenges in drug research. We sincerely hope that you will take this opportunity to join us for academic exchange and business partnership. On behalf of the organizing committee, we highly appreciate your support and understanding.

The organizing committee of WCDI

 

 

Welcome Message

 

Welcome to attend World Congress on Drug Innovation (WCDI-2021) during August 12-14, 2021 in Shanghai, China. We cordially invite all the participants interested in sharing their knowledge and research in the arena of drug discovery and delivery.

WCDI-2021 provide a significant platform for inspiring international and interdisciplinary exchange at the forefront of drug research and to accelerate the cooperation for new drug research and development, and novel DDS technologies in the global market. The conference feature talks from Recent Advancements on Drug Discovery Science and Technology to Novel Drug Delivery Systems and Technology. The scientific program will feature plenary forum I for drug discovery, plenary forum II for drug delivery, 30+ breakout sessions, panel discussion, networking activities, poster showcase and exhibitions. Our endeavor is to provide a stimulating and thought provoking scientific program.

WCDI-2021 will bring together scientists, researchers, entrepreneurs, academicians, medical officers, and decision makers from all over the world to debate on the latest scientific advances in the field of drug discovery & delivery that help to shape current and future challenges in drug research.
Finally, we sincerely hope that you will take this opportunity to join us for academic exchange and business partnership. Look forward to meeting you in this great city of Shanghai, China.

 

 

Honorary Chairman

 

Chong-Su Cho, Fellow of Korean Academy of Science and Technology, Fellow of International Union of Societies for Biomaterials Science and Engineering;
Research Professor, Research Institute for Agriculture and Life Sciences, Seoul National University, South Korea
Learn More
   

Renowned Speakers

Chong-Su Cho, Fellow of Korean Academy of Science and Technology, Fellow of International Union of Societies for Biomaterials Science and Engineering;
Research Professor, Research Institute for Agriculture and Life Sciences, Seoul National University, South Korea
Dr. Feng Qian, Professor and Vice Dean, School of Pharmaceutical Sciences, Tsinghua University, China
       
Dr. C. I.Edvard SMITH, Professor, Karolinska Institutet, Sweden Dr. Richard Soll, Senior Vice President, Research Service Division, WuXi AppTec, USA
       
Dr. Qun (Max) Dang, Corporate Vice President, CSPC PHARMA LTD, China

Dr. Jing Li, Senior Vice President, WuXi Biologics, China

       
Dr. Tomasz Janecki, Professor, Director of the Institute of Organic Chemistry, Lodz University of Technology, Poland Dr. Hong Ling, CSO&SVP, Leads Biolabs, China
       
Dr. Marco Falasca, Professor, Head Metabolic Signaling Group, School of Pharmacy & Biomedical Sciences, Faculty of Health Sciences, Curtin University, Australia Dr. Ketan Mehta, Founder and CEO, Tris Pharma Inc., USA
       
Yueqing Gu, Professor, Biomedical Engineering; Dean, School of Engineering; Director, Molecular imaging and Biomedical Engineering
China Pharmaceutical University, China
Dr.Kiyoshi NOKIHARA,Professor, CEO & CSO, HiPep Laboratories, Japan
       
Jun-Kyu Suh, M.D, Ph.D, Inha-Hanlym Distinguished Professor, National Research Center for Sexual Medicine, Dept. of Urology, Inha University School of Medicine, South Korea

Insang Lee, CEO of Divine Lab Co Ltd., South Korea

       
Kiminobu Sugaya, Professor and Head of Neuroscience, Chair of Multidisciplinary Neuroscience Alliance, College of Medicine, University of Central Florida, Orlando FL, USA Urban Fagerholm, Associate Professor, CEO at PROSILICO, Huddinge, Sweden
       
Vivek (Vic) Kadambi, Ph.D., Senior Vice President, Quantitative Pharmacology & Drug Safety, Blueprint Medicines, USA    
   
 
 
 
 
Copyright © 2019-2021 ISTCI.ORG All Rights Reserved.